List view / Grid view
21 December 2015 | By Victoria White
Bayer and CRISPR Therapeutics are to form the joint venture to discover, develop and commercialise new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease...
21 December 2015 | By Victoria White
Their goal is to develop a therapeutic vaccine which aims to intercept HPV infection-related disease, particularly in those who are diagnosed with HPV early, by enhancing the ability of the immune system to treat chronic infections and prevent progression to cancer...
18 December 2015 | By Victoria White
Variant says VAR 200 has potential for treating multiple indications associated with the damaging effects of cellular accumulation of cholesterol and lipids on the kidney, including focal segmental glomerulosclerosis...
18 December 2015 | By Victoria White
OMT has leading antibody drug discovery technology and is believed to be the only company in the world offering three transgenic animal platforms for license...
17 December 2015 | By Victoria White
When given to mice, the new ‘homing’ agent inactivated the complement system in the brain, reduced inflammation and aided recovery...
17 December 2015 | By Victoria White
The Scientific Advisory Board comprises nine leading academics and industry executives with a world-class breadth of expertise across the Company’s areas of operation...
17 December 2015 | By Victoria White
The new premises will accommodate the Company’s US clinical development, medical and regulatory operations and provide an important base for Immunocore’s ongoing US activities...
15 December 2015 | By Victoria White
There are thought to be as many as 600,000 protein-protein interactions that could be targets for new drugs. The project seeks to analyse and categorise the important features of these interactions...
15 December 2015 | By Victoria White
Researchers have shown that the presence or absence of the CAP2 gene causes sudden cardiac death in mice...
15 December 2015 | By Victoria White
The "Takeda-CiRA Joint Programme for iPS Cell Applications" (T-CiRA) will begin research in six core directions to explore clinical applications of stem cells in therapeutic areas including cancer, heart failure and diabetes mellitus...
15 December 2015 | By Victoria White
The new facility will support science- and technology-based companies striving to build businesses that originated with research from universities and increase their impact...
15 December 2015 | By Victoria White
A new study, conducted by researchers at the Karolinska Institutet and Gothenburg University, describes a possible mechanism for how the gene variant produces clinical symptoms by affecting levels of specific proteins in the brain...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
14 December 2015 | By Victoria White
Their research identified eight complete strains of human pegivirus 2, which makes it the first study to reveal the entire genetic makeup of this new virus...
14 December 2015 | By Victoria White
Bristol-Myers Squibb and the David Geffen School of Medicine at UCLA will conduct a range of early phase clinical studies as part of the I-O RPM research programme...
